Microbiome Analysis Service Supply Contract Worth KRW 2.08 Billion with HEM Pharma Japan
-
Signed a contract with HEM Pharma Japan Inc. (subsidiary) for microbiome analysis service supply
-
Contract amount: KRW 2,084,434,000 (JPY 220 million, exchange rate JPY100/KRW947.47)
-
Equivalent to 16.06% of recent revenue (consolidated, end-2025)
-
Contract period: 2026-05-14 to 2027-05-13 (1 year)
-
Payment: within 60 days of invoice, advance payment negotiable
-
Counterparty is a subsidiary, thus an intercompany transaction on a consolidated basis
KOSDAQ Filing Information
-
Filing: Conclusion of a Single Sales and Supply Contract
-
Company: HEM Pharma (376270)
-
Submission: HEM Pharma Inc.
-
Receipt: 05-14-2026
-
Under KRX KOSDAQ Market Division